FDA Expands Nevisense Use to More Healthcare Professionals in the U.S.

March 06, 2026
SciBase has received FDA approval to expand the labeling of its AI-based skin diagnostic tool, Nevisense, allowing physician assistants and medical assistants to perform the procedure under dermatologist supervision.

SciBase has received FDA approval to extend the labeling of its AI-based skin diagnostic device Nevisense, announced in a press release. The updated labeling now allows physician assistants and medical assistants in dermatology clinics to perform the Nevisense procedure, provided a dermatologist initiates the test.

Previously, only dermatologists were authorized to perform Nevisense measurements. The change aims to make the technology easier to integrate into clinical workflows and expand its accessibility to patients. Nevisense combines electrical impedance spectroscopy (EIS) with AI to assist in the detection of skin disorders, including melanoma.

According to SciBase, the broader labeling will enable more efficient use of Nevisense in dermatology practices and labs, supporting its adoption across the U.S. market.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

03/06
Third Way Health Raises $15M Series A to Expand AI Healthcare Operations
03/05
DentScribe Receives USPTO Notice of Allowance for AI Dentistry Patent
03/05
Senhwa Biosciences Signs AI-Driven Drug Development Partnership with CellType
03/05
Procode AI Launches with $4 Million and Acquires The Auctus Group
03/05
Droplet Biosciences Cuts Cancer Genomic Analysis Time with NVIDIA GPUs

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like